All lobbying filings
DLA PIPER LLP (US)
DLA PIPER LLP (US) filed a Q3 termination report for CURRAX PHARMACEUTICALS LLC on October 20, 2026, reporting no lobbying activity.
Lobbying for CURRAX PHARMACEUTICALS LLC · Specialty pharmaceutical business
Filing · LD-2 quarterly report
Q3 terminationNo activity
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 20, 2026
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
Tennessee
Representation ended
Jul 1, 2026
The registrant reported terminating its work for this client.
Lobbying activity
0
No itemized activity in this filing.